EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART)

Avani C Modi iD, Janelle L Wagner, Anup D Patel iD, Stacy Buschhaus, Matthew Schmidt, Heather Huszti, Tracy A Glauser, Marie Davidian

Epilepsia · 2026-04 · 67 (4) · 1975-1991

DOI: 10.1002/epi.70097 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, online erschienen am 24.01.2026. Verfasst von Avani C Modi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Epilepsy, Anticonvulsants, Medication Adherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Nonadherence to antiseizure medications in pediatric epilepsy affects ~60% of youth. The aim of this multisite two‐stage sequential, multiple assignment, randomized trial (SMART) was to evaluate the effectiveness of mHealth intervention strategies for improving adherence in caregivers of young children with epilepsy, particularly those who are underserved. It was hypothesized that participants initially randomized to treatment would exhibit significantly greater improvements in adherence compared to an active control group at the end of stage 1. Secondary outcomes included longitudinal adherence, seizure freedom/severity, and health‐related quality of life.

Methods

Participants across four epilepsy centers were recruited ( n = 461, mean age = 7.6 ± 3.0 years, 51% males, 62% White non‐Hispanic, 71% underserved). Baseline questionnaires were completed, and electronic adherence monitors were provided. Three intervention strategies were embedded in this SMART: (1) active control (mHealth education + automated digital reminders), (2) treatment (mHealth education + automated digital reminders + individualized adherence feedback) in stage 1 continuing in stage 2 regardless of responsiveness in stage 1, and (3) treatment in stage 1 continuing in stage 2 if patient is responsive in stage 1 or augmented by problem‐solving if patient is nonresponsive in stage 1. Active intervention was 5 months, with two posttreatment follow‐ups. Standard analysis of covariance was conducted for the primary aim. Secondary analyses compared mean change from baseline associated with each intervention strategy.

Results

The treatment group had significantly better mean adherence percentage change from baseline to the end of stage 1 compared to the active control group (13.2% vs. 3.1% change, t = 2.82, p = .005, d = .37). Adherence rates declined over time across all SMART strategies. An increased probability of seizure freedom at 6 and 12 months across all SMART strategies was found. Significance This pediatric epilepsy SMART trial demonstrated adherence improvements for the treatment group that did not persist over time. Improvements in seizure freedom that were independent of SMART strategy were also identified. mHealth education, automated digital reminders, and individualized adherence feedback appear to have been efficacious.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnticonvulsantsMedication AdherenceHumansMaleChildFemaleTelemedicineAdherence InterventionsCaregiversQuality of LifeChild, PreschoolReminder SystemsDigital Health

Stichwörter der Autor:innen

behavioral interventioncaregiverschildrenseizureself‐management

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • University of Cincinnati, College of Medicine, Cincinnati, Ohio, USA.
  • College of Nursing, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Neurology, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Mary Frances Early College of Education, College of Pharmacy, University of Georgia, Athens, Georgia, USA.
  • Children's Hospital of Orange County, Orange, California, USA.

ORCID-Profile: Avani C Modi, Anup D Patel

Förderung

  • NINR NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Modi, A. C., Wagner, J. L., Patel, A. D., Buschhaus, S., Schmidt, M., Huszti, H., Glauser, T. A., & Davidian, M. (2026). mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART). Epilepsia, 67(4), 1975-1991. https://doi.org/10.1002/epi.70097

Vancouver

Modi AC, Wagner JL, Patel AD, Buschhaus S, Schmidt M, Huszti H, et al. mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART). Epilepsia. 2026;67(4):1975-1991. doi:10.1002/epi.70097

BibTeX
@article{Modi2026,
  author = {Modi, Avani C and Wagner, Janelle L and Patel, Anup D and Buschhaus, Stacy and Schmidt, Matthew and Huszti, Heather and Glauser, Tracy A and Davidian, Marie},
  title = {mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART)},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {4},
  pages = {1975--1991},
  doi = {10.1002/epi.70097}
}
Kostenlos starten →